These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28102)

  • 1. Standard and long-acting depot neuroleptics in chronic schizophrenics: an 18-month open multicentric study.
    Simon P; Fermanian J; Ginestet D; Goujet MA; Péron-Magnan P
    Arch Gen Psychiatry; 1978 Jul; 35(7):893-7. PubMed ID: 28102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How schizophrenic patients change during 3 years' treatment with depot neuroleptics.
    Dencker SJ; Frankenberg K; Lepp M; Lindberg D; Malm U
    Acta Psychiatr Scand; 1978 Feb; 57(2):115-23. PubMed ID: 24982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three years' maintenance neuroleptic treatment in schizophrenia--before and beyond.
    Dencker SJ; Frankenberg K; Lepp M; Lindberg D; Malm U
    Acta Psychiatr Scand; 1978 Feb; 57(2):103-14. PubMed ID: 24981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of the effects of pipothiazine palmitate and fluphenazine decanoate. Results of a multicenter double-blind trial].
    Woggon B; Dick P; Fleischhauer HJ; Gmür M; Gruber G; Angst J; Heimann H
    Int Pharmacopsychiatry; 1977; 12(4):193-209. PubMed ID: 22515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMDP psychopathology factors in chronic schizophrenia: a clinical trial of two long-acting neuroleptics.
    Lapierre YD; von Frenckell R
    Mod Probl Pharmacopsychiatry; 1983; 20():193-203. PubMed ID: 6137766
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative study of pipothiazine palmitate and fluphenazine decanoate in the maintenance of remission of schizophrenia.
    Leong OK; Wong KE; Tay WK; Gill RC
    Singapore Med J; 1989 Oct; 30(5):436-40. PubMed ID: 2575796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients.
    Walker CA
    Pharmatherapeutica; 1983; 3(5):289-93. PubMed ID: 6133287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled clinical evaluation of depot neuroleptics. A double-blind trial with pipotiazine undecylenate and fluphenazine enanthate.
    Ahlfors UG
    Acta Psychiatr Scand Suppl; 1973; 241():95-9. PubMed ID: 4147516
    [No Abstract]   [Full Text] [Related]  

  • 9. Depot pipotiazine 1970-1982: a review.
    Burch EA; Ayd FJ
    J Clin Psychiatry; 1983 Jul; 44(7):242-7. PubMed ID: 6134718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depot fluphenazine decanoate and enanthate for schizophrenia.
    David A; Adams CE; Eisenbruch M; Quraishi S; Rathbone J
    Cochrane Database Syst Rev; 2005 Jan; (1):CD000307. PubMed ID: 15674872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind controlled study of pipothiazine palmitate in the maintenance treatment of schizophrenic outpatients.
    Chouinard G; Annable L; Kropsky M
    J Clin Pharmacol; 1978; 18(2-3):148-54. PubMed ID: 24061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study with pipothiazine palmitate and fluphenazine enanthate in the treatment of schizophrenic patients.
    Jain RC; Ananth JV; Lehmann HE; Ban TA
    Curr Ther Res Clin Exp; 1975 Oct; 18(4):585-9. PubMed ID: 241609
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative study of four evaluation criteria in a clinical trial with schizophrenic patients.
    Fombonne E; Peron-Magnan P; Fuhrer R; Simon P
    Neuropsychobiology; 1986; 16(4):186-92. PubMed ID: 2886952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Kong DS; Yeo SH
    Pharmatherapeutica; 1989; 5(6):371-9. PubMed ID: 2687894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pipotiazine palmitate: a new depot neuroleptic.
    Simpson GM; Varga V
    Curr Ther Res Clin Exp; 1975 Mar; 17(3):276-80. PubMed ID: 236151
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and social comparison of fluphenazine decanoate and flupenthixol decanoate in the community maintenance therapy of schizophrenia.
    Kelly HB; Freeman HL; Banning B; Schiff AA
    Int Pharmacopsychiatry; 1977; 12(1):54-64. PubMed ID: 406212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eleven years of experience with depot neuroleptics.
    Gross H; Kaltenbäck E; Pfolz H
    Acta Psychiatr Belg; 1981; 81(2):128-32. PubMed ID: 6117183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled one-year study of pipotiazine palmitate and fluphenazine decanoate in chronic schizophrenic syndromes. Evaluation of results at 6 and 12 months' trial.
    Dencker SJ; Frankenberg K; Malm U; Zell B
    Acta Psychiatr Scand Suppl; 1973; 241():101-18. PubMed ID: 4147508
    [No Abstract]   [Full Text] [Related]  

  • 19. Low dose medication strategies in the maintenance treatment of schizophrenia.
    Kane JM
    Schizophr Bull; 1983; 9(4):528-32. PubMed ID: 6140751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do schizophrenics well adapted in the community need neuroleptics? A depot neuroleptic withdrawal study.
    Dencker SJ; Lepp M; Malm U
    Acta Psychiatr Scand Suppl; 1980; 279():64-76. PubMed ID: 6105763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.